These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 3897398)

  • 1. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci.
    Swingle HM; Bucciarelli RL; Ayoub EM
    J Infect Dis; 1985 Sep; 152(3):515-20. PubMed ID: 3897398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic-killing kinetics of group B streptococci.
    Schauf V; Deveikis A; Riff L; Serota A
    J Pediatr; 1976 Aug; 89(2):194-8. PubMed ID: 781200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimum choice of antibiotic treatment in neonatal infections due to group B streptococci].
    Bingen E; Lambert-Zechovsky N; Guihaire E; Mancy C; Aujard Y; Mathieu H
    Pathol Biol (Paris); 1986 May; 34(5):530-3. PubMed ID: 3534738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal studies of penicillin-gentamicin combinations against group B streptococci.
    Overturf GD; Horowitz M; Wilkins J; Leedom J; Steinberg E
    J Antibiot (Tokyo); 1977 Jun; 30(6):513-8. PubMed ID: 328471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to six antibiotics of group B streptococci isolated from cerebrospinal fluid.
    Mulder C; Bol P; Nabbe A; Zanen B
    Scand J Infect Dis; 1985; 17(2):191-3. PubMed ID: 3895400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse during penicillin treatment of group B streptococcal meningitis.
    Dorand RD; Adams G
    J Pediatr; 1976 Aug; 89(2):188-90. PubMed ID: 781198
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci.
    Baker CN; Thornsberry C; Facklam RR
    Antimicrob Agents Chemother; 1981 May; 19(5):716-25. PubMed ID: 7027921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of cefotaxime and ceftriaxone alone and in combination with penicillin, ampicillin and piperacillin against neonatal meningitis pathogens.
    Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1985 Sep; 16(3):327-34. PubMed ID: 3932295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of bactericidal activity against group B streptococci with reduced penicillin susceptibility by uptake of gentamicin into cells resulting from combination with β-lactam antibiotics.
    Ebara Y; Morozumi M; Sato M; Moritoki N; Toyofuku M; Takata M; Murata M; Ubukata K; Iwata S
    J Infect Chemother; 2017 May; 23(5):312-318. PubMed ID: 28341517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
    Landesman SH; Corrado ML; Cherubin CE; Sierra MF
    Antimicrob Agents Chemother; 1981 May; 19(5):794-7. PubMed ID: 6271048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillin tolerance in group B streptococci isolated from infected neonates.
    Kim KS; Anthony BF
    J Infect Dis; 1981 Nov; 144(5):411-9. PubMed ID: 7031141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antimicrobial therapy for experimental infections due to group B Streptococcus on mortality and clearance of bacteria.
    Kim KS
    J Infect Dis; 1987 Jun; 155(6):1233-41. PubMed ID: 3553349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is gentamicin necessary in the antimicrobial treatment for group B streptococcal infections in the elderly? An in vitro study with human blood products.
    Ruppen C; Decosterd L; Sendi P
    Infect Dis (Lond); 2017 Mar; 49(3):185-192. PubMed ID: 27766925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.
    Cercenado E; Díaz MD; Sánchez-Carrillo C; Vicente T; Bernaldo de Quirós JC
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2816-8. PubMed ID: 8593029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Neonatal group B streptococcal infection.
    McCracken GH; Feldman WE
    J Pediatr; 1976 Aug; 89(2):203-4. PubMed ID: 781202
    [No Abstract]   [Full Text] [Related]  

  • 16. [Infections in newborn infants caused to B-streptococci].
    Günther E; Knöll H; Köhler W
    Zentralbl Gynakol; 1976; 98(17):1075-8. PubMed ID: 790843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serious infection in an adult due to penicillin-tolerant group B streptococcus.
    Steinbrecher UP
    Arch Intern Med; 1981 Nov; 141(12):1714-5. PubMed ID: 7030251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of gentamycin combined with beta-lactam antibiotics against penicillin-resistant and non-resistant Streptococcus agalactiae].
    Villar H; Jugo M; Farinati A
    Enferm Infecc Microbiol Clin; 1994 Oct; 12(8):385-9. PubMed ID: 7981289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial therapy of experimental group B streptococcal infection in mice.
    Deveikis A; Schauf V; Mizen M; Riff L
    Antimicrob Agents Chemother; 1977 May; 11(5):817-20. PubMed ID: 327920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High rate of slowly-killed-by-ampicillin phenotype among group B streptococci with reduced penicillin susceptibility.
    Taniguchi R; Kimura K; Miyazaki A; Banno H; Jin W; Yamada K; Wachino JI; Arakawa Y
    J Antimicrob Chemother; 2017 Mar; 72(3):941-942. PubMed ID: 27999012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.